Oral Oncology
Volume 46, Issue 5 , Pages e34-e37 , May 2010

Evaluation of natural killer cell defense in oral squamous cell carcinoma

  • Mahiye Reyhan Türkseven

      Affiliations

    • Ministry of Health, Balgat Health Center of Mouth and Teeth, Barış Manço Caddesi No. 22, Ankara, Turkey
    • Tel.: +90 312 284 26 79.
    • ,
  • Tülin Oygür

      Affiliations

    • Gazi University, Faculty of Dentistry, Department of Oral Pathology, 06510 Emek Mahallesi, Ankara, Turkey
    • Corresponding Author InformationCorresponding author. Tel.: +90 312 203 43 80; fax: +90 312 223 92 26.

Received 8 January 2010 ,Revised 19 February 2010 ,Accepted 19 February 2010.

References 

  1. The World Health Report 1998. Life in the 21st century. A vision for all. Report of the Director General. World Health Organization 1998;103:88–90.
  2. Odel EW, Morgan PR. Biopsy pathology of the oral tissues. 1st ed.. London: Chapman and Hall; 1998;
  3. Cotran RS, Kumar V, Collins T. Robbin’s pathologic basis of disease. 6th ed.. Philadelphia: WB Saunders Co.; 1999;
  4. Whiteside TL, Letessier E, Hirabayashi H, Vitolo D, Bryant J, Barnes L, et al. Evidence for local and systemic activation of immune cells by peritumoral injections of interleukin 2 in patients with advanced squamous cell carcinoma of head and neck. Cancer Res. 1993;53:5654–5662
  5. Ishigami S, Natsugoe S, Tokuda K, Nakajo A, Che X, Iwashige H, et al. Prognostic value of intratumoral natural killer cells in gastric carcinoma. Cancer. 2000;88:553–577
  6. Miller JS. Biology of natural killer cells in cancer and infection. Cancer Invest. 2002;20(3):405–419
  7. Partridge M, Li SR, Pateromichelakis S, Francis R, Phillips E, Huang XH, et al. Detection of minimal residual cancer to investigate why oral tumors recur despite seemingly adequate treatment. Clin Cancer Res. 2000;6(7):2718–2725
  8. Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ. Manual for staging of cancer. American joint committee on cancer. 4th ed.. Philadelphia: Lippincott; 1992;
  9. Bryne M, Koppang HS, Lilleng R, Stene T, Bang G, Dabelsteen E. New malignancy grading is a prognostic indicator than Broder’s grading in oral squamous cell carcinoma. J Oral Pathol Med. 1989;18:432–437
  10. Whiteside TL, Chikamatsu K, Nagashima S, Okada K. Antitumor effects of cytolytic T lymphocytes (CTL) and natural killer (NK) cells in head and neck cancer. Anticancer Res. 1996;16:2357–2364
  11. Foss FM. Immunologic mechanism of antitumor activity. Semin Oncol. 2002;29(Suppl. 7):5–11
  12. Garrido F, Algarra I. MHC antigens and tumor escape from immune surveillance. Adv Cancer Res. 2001;83:117–158
  13. Cabrera T, Salinero J, Fernandez MA, Garrido A, Esquivias J, Garrido F. High frequency of altered HLA class I phenotypes in laryngeal carcinomas. Hum Immunol. 2000;61(5):499–506
  14. Esteban F, Concha A, Delgado M, Perez-Ayala M, Ruiz-Cabello F, Garrido F. Lack of MHC class I antigens and tumor aggressiveness of the squamous cell carcinoma of the larynx. Brit J Cancer. 1990;62:1047–1051
  15. Cruz I, Meijer CJLM, Walboomers JMM, Snijders PJF, Van Der Waal I. Lack of MHC class I surface expression on neoplastic cells and poor activation of the secretory pathway of cytotoxic cells in oral squamous cell carcinomas. Brit J Cancer. 1999;81(5):881–889
  16. Schantz SP, Ordonez NG. Quantitation of natural killer cell function and risk of metastatic poorly differentiated head and neck cancer. Nat Immun Cell Growth Regul. 1991;10(5):278–288
  17. Kurosawa S, Harada M, Matsızaki G, Shinomiya Y, Terao H, Kobayashi N. Early-appearing tumor-infiltrating natural killer cells play a crucial role in the generation of antitumor T lymphocytes. Immunology. 1995;85:338–346
  18. Harabuchi Y, Yamanaka N, Kataura A. Identification of lymphocytes subsets and natural killer cells in head and neck cancers. Arch Otorhinolaryngol. 1985;242:89–97
  19. Ugolini S, Vivier E. Regulation of T cell function by NK cell receptors for classical MHC class I molecules. Curr Opin Immunol. 2000;12(3):295–300
  20. Paul P, Rouas-Freiss N, Khalil-Daher I, Moreau P, Riteau B, Le Gal FA, et al. HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance. Proc Natl Acad Sci USA. 1998;95(8):4510–4515
  21. Aractingi S, Kanitakis J, Eurrard S, Le Danff C, Carosella ED. Selective expression of HLA-G in malignant and premalignant skin specimens in kidney transplant recipients. Int J Cancer. 2003;106(2):232–235
  22. Mann EA, Hibbs MS, Spiro JD, Bowik C, Wang XS, Clawson M, et al. Cytokine regulation of gelatinase production by head and neck squamous cell carcinoma: the role of the tumor necrosis factor-alpha. Ann Otol Rhino Laryngol. 1995;104(3):203–209
  23. Jewett A, Cavalcanti M, Bonavida B. Pivotal role of endogenous TNFα in the induction of functional inactivation and apoptosis in NK cells. J Immunol. 1997;159:4815–4822
  24. Suvendu Das C, Varalakshmi AK. Target-cell-induced anergy in natural killer cells: suppression of cytotoxic function. Cancer Immunol Immunother. 2000;49:109–115

PII: S1368-8375(10)00066-7

doi: 10.1016/j.oraloncology.2010.02.019

Oral Oncology
Volume 46, Issue 5 , Pages e34-e37 , May 2010

Article Tools

* Image Usage & Resolution